Atlas Trials

Study of Mantle Cell Lymphoma Treatment by RiBVD

Clinical trial NCT01457144 · COMPLETED

Trial details

NCT number
NCT01457144
Sponsor
French Innovative Leukemia Organisation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mantle Cell Lymphoma
Start date
2011-10-01
Primary completion
2014-09-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.